Literature DB >> 27511592

Efficacy of fluralaner in 17 dogs with sarcoptic mange.

Camilo Romero1, Rafael Heredia2, Jocelyn Pineda3, Jonathan A Serrano4, Germán D Mendoza5, Porfirio Trápala6, Alberto M Cordero7.   

Abstract

BACKGROUND: There are few licensed options for the treatment of canine sarcoptic mange.
OBJECTIVE: To evaluate the efficacy of fluralaner in dogs with sarcoptic mange infestation. ANIMALS: Seventeen dogs with a diagnosis of Sarcoptes scabiei based on positive skin scrapings.
METHODS: A single dose of oral fluralaner was administered according to the manufacturer's instructions. Assessments of pruritus and lesions were performed every 7 days for 1 month.
RESULTS: By Day 14 post-treatment, skin scrapings from all dogs were negative for mites. At the beginning of the study there was a negative correlation between body weight of the subject and pruritus [Pearson correlation coefficient (PCC) = -0.396, P = 0.007] and a positive correlation between pruritus and lesion severity (PCC 0.755, P = 0.0001). Significant decreases in lesion size and pruritus were observed within the first 14-21 days, respectively, and improvement in these parameters continued until the end of the study at Day 28.
CONCLUSION: Fluralaner was effective in eliminating scabies mites within 14 days and significantly resolved the clinical signs associated with sarcoptic mange within 21 days after a single dose.
© 2016 ESVD and ACVD.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27511592     DOI: 10.1111/vde.12363

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  6 in total

1.  Oral fluralaner as a treatment for Demodex aurati and Demodex criceti in a golden (Syrian) hamster (Mesocricetus auratus).

Authors:  Gabrielle Brosseau
Journal:  Can Vet J       Date:  2020-02       Impact factor: 1.008

2.  Efficacy and Pharmacokinetics Evaluation of a Single Oral Dose of Afoxolaner against Sarcoptes scabiei in the Porcine Scabies Model for Human Infestation.

Authors:  Charlotte Bernigaud; Fang Fang; Olivier Chosidow; Jacques Guillot; Katja Fischer; Anne Lespine; Ludwig S Aho; Amanda J Mullins; Berhane Tecle; Andrew Kelly; Jean-François Sutra; Francis Moreau; Thomas Lilin; Frédéric Beugnet; Françoise Botterel
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

3.  Efficacy of afoxolaner plus milbemycin oxime and afoxolaner alone as treatment for sarcoptic mange in naturally infested dogs.

Authors:  Camilo Romero-Núñez; Linda G Bautista-Gómez; Galia Sheinberg; Alberto Martín-Cordero; Ariadna Flores-Ortega; Rafael Heredia-Cárdenas
Journal:  Can J Vet Res       Date:  2020-07       Impact factor: 1.310

4.  Efficacy of orally and topically administered fluralaner (Bravecto®) for treatment of client-owned dogs with sarcoptic mange under field conditions.

Authors:  Rafael Chiummo; Ivo Petersen; Claudia Plehn; Eva Zschiesche; Rainer Roepke; Emmanuel Thomas
Journal:  Parasit Vectors       Date:  2020-10-17       Impact factor: 3.876

5.  Fluralaner as a novel treatment for sarcoptic mange in the bare-nosed wombat (Vombatus ursinus): safety, pharmacokinetics, efficacy and practicable use.

Authors:  Vicky Wilkinson; Kotaro Takano; David Nichols; Alynn Martin; Roz Holme; David Phalen; Kate Mounsey; Michael Charleston; Alexandre Kreiss; Ruth Pye; Elizabeth Browne; Christina Næsborg-Nielsen; Shane A Richards; Scott Carver
Journal:  Parasit Vectors       Date:  2021-01-06       Impact factor: 3.876

6.  Efficacy and safety assessment of a water-soluble formulation of fluralaner for treatment of natural Ornithonyssus sylviarum infestations in laying hens.

Authors:  Nancy C Hinkle; Faris Jirjis; Eugene Szewczyk; Fangshi Sun; Annie Flochlay-Sigognault
Journal:  Parasit Vectors       Date:  2018-02-20       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.